Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,164 | -52,932 | -236,568 | -180,703 | -147,417 |
| Depreciation Amortization | 4,822 | 1,924 | 7,976 | 5,994 | 4,040 |
| Income taxes - deferred | -4,939 | -4,939 | 9 | N/A | N/A |
| Accounts receivable | 2,705 | -1,367 | -17,330 | -7,426 | -4,424 |
| Other Working Capital | -15,944 | -3,152 | -39,880 | 11,427 | 14,541 |
| Other Operating Activity | 75,318 | 42,397 | 119,218 | 84,905 | 59,083 |
| Operating Cash Flow | $-34,202 | $-18,069 | $-166,575 | $-85,803 | $-74,177 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 90,400 | 38,197 | 92,671 | 160,109 | 85,731 |
| PPE Investments | -4,144 | -1,942 | -355 | -1,089 | -1,226 |
| Investing Cash Flow | $86,256 | $36,255 | $92,316 | $159,020 | $84,505 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -51 | -28 | -283 | -92 | -41 |
| Common Stock Issued | 30,970 | 5,009 | 4,310 | 3,191 | 1,858 |
| Common Stock Repurchased | -14,008 | -12,806 | -11,490 | -11,119 | -9,278 |
| Other Financing Activity | -1,063 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $15,848 | $-7,825 | $-7,463 | $-8,020 | $-7,461 |
| Exchange Rate Effect | -6,684 | 1,507 | -14,619 | -33,120 | -12,462 |
| Beginning Cash Position | 153,115 | 153,115 | 249,456 | 249,456 | 249,456 |
| End Cash Position | 214,333 | 164,983 | 153,115 | 281,533 | 239,861 |
| Net Cash Flow | $61,218 | $11,868 | $-96,341 | $32,077 | $-9,595 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,202 | -18,069 | -166,575 | -85,803 | -74,177 |
| Capital Expenditure | -4,144 | -1,942 | -3,766 | -1,089 | -1,226 |
| Free Cash Flow | -38,346 | -20,011 | -170,341 | -86,892 | -75,403 |